The 20 Best Lewy Body Dementia (LBD) Doctors Near Me in Ann Arbor, MI

Henry L. Paulson, M.D., Ph.D., is the Lucile Groff Professor of Neurology for Alzheimer's Disease and Related Disorders in the Department of Neurology at the University of Michigan. Dr. Paulson joined the U-M faculty in 2007, and he currently directs the Michigan Alzheimer’s Disease Center (MADC) and co-direct the U-M Protein Folding Diseases Initiative.Dr. Paulson received his medical degree and doctorate in Cell Biology from Yale University in 1990. He then completed a neurology residency and neurogenetics/movement disorders fellowships at the University of Pennsylvania. In 1997, he joined the Neurology faculty at the University of Iowa, where he remained until 2007.Dr. Paulson's research and clinical interests concern the causes and treatment of age-related neurodegenerative diseases, with an emphasis on polyglutamine diseases, Alzheimer's disease and frontotemporal dementia. In 1997, his lab described abnormal protein aggregates in the polyglutamine diseases, which now are recognized as a pathological hallmark in this important class of inherited diseases. Using test tube, cell-based and animal models, he has contributed to advances in the understanding of various neurodegenerative diseases. His lab also has helped pioneer the use of gene silencing methods as potential therapy for the many neurological disorders caused by toxic mutant genes.Nationally, Dr. Paulson has directed popular courses at the American Academy of Neurology meetings, serves on the scientific advisory boards of numerous disease-related national organizations, and is past Chair of the Board of Scientific Counselors at the National Institute for Neurological Disorders and Stroke at the National Institutes of Health.Among his awards, Dr. Paulson is an Ellison Medical Foundation New Scholar in Aging, a semifinalist for the W.M. Keck Foundation Young Scholars in Medical Research, and a recipient of the Paul Beeson Physician Faculty Scholar in Aging Award from the American Federation for Aging Research. Dr. Paulson is rated as a Distinguished provider by MediFind in the treatment of Lewy Body Dementia (LBD). He is also highly rated in 41 other conditions, according to our data. His clinical expertise encompasses Spinocerebellar Ataxia Type 3, Olivopontocerebellar Atrophy, Spinocerebellar Ataxia, and Drug Induced Dyskinesia. Dr. Paulson is board certified in Neurology.

Judith Heidebrink is a Neurologist practicing medicine in Ann Arbor, Michigan. Dr. Heidebrink is rated as a Distinguished provider by MediFind in the treatment of Lewy Body Dementia (LBD). She is also highly rated in 16 other conditions, according to our data. Her clinical expertise encompasses Alzheimer's Disease, Cerebellar Degeneration, Lewy Body Dementia (LBD), and Dementia.

Sami Barmada, M.D., Ph.D. is an assistant professor of neurology at the University of Michigan Medical School. His clinical interests center around patients with dementia and motor neuron disease, and he sees patients at the Cognitive Disorders Clinic in the University of Michigan’s East Ann Arbor location.His research focuses on the pathologic overlap between amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), and how we can take advantage of the convergence to identify new and effective therapies for these devastating disorders.After graduating from the University of Pittsburgh, Pennsylvania, in 1998 with a major in Molecular Biology, Biochemistry, and a focus in Conceptual Foundations of Medicine, Dr. Barmada went on to the Medical Scientist Training Program at Washington University in St. Louis School of Medicine. For his graduate work, he constructed a transgenic mouse model of Creutzfeldt-Jacob disease with Dr. David Harris, and used these animals to track the deposition of misfolded prion protein within the nervous system of infected animals. For this work, Dr. Barmada earned earned the Poletsky Award from the Alzheimer’s Disease Research Center in St. Louis, Missouri, and was elected as a Olin Medical Scientist Fellow at Washington University School of Medicine.Dr. Barmada received his M.D. and Ph.D. in 2006, and completed an Internal Medicine internship at Washington University School of Medicine and Barnes-Jewish Hospital in St. Louis, Missouri, before moving to the University of California, San Francisco (UCSF), Medical Center for his residency in Neurology. Dr. Barmada served one year as Chief Resident in the Department of Neurology, focusing on resident education. He was also a house-staff nominee to the Alpha-Omega-Alpha honor society. During his residency, Dr. Barmada became involved in research with Dr. Steve Finkbeiner of the Gladstone Institutes, a pioneer in neuronal models of neurodegenerative disease and novel technologies to study these models. Dr. Barmada finished his residency in 2010 and spent one year working with Dr. Finkbeiner as a research fellow, before becoming a Staff Scientist at the Gladstone Institutes and a Clinical Instructor at UCSF. In 2013, Dr. Barmada became an Assistant Professor of Neurology at the University of Michigan, where he divides his time between the Cognitive Disorders Clinic and the laboratory. Dr. Barmada is rated as a Distinguished provider by MediFind in the treatment of Lewy Body Dementia (LBD). He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, Frontotemporal Dementia, and Dementia. Dr. Barmada is board certified in Neurology.

Dr. Praveen Dayalu is an Associate Professor and the Thomas H. and Susan C. Brown Early Career Professor of Neurology at the University of Michigan. He graduated from medical school at Case Western Reserve University in Cleveland, in 2002, and then completed neurology residency and movement disorders fellowship at Michigan, in 2006. His main focus is clinical management of movement disorders, especially Parkinson disease. His research interests are in Huntington disease and Multiple System Atrophy. He is the Director of the Movement Disorders Fellowship and trains fellows, residents, and medical students. Dr. Dayalu is rated as a Distinguished provider by MediFind in the treatment of Lewy Body Dementia (LBD). He is also highly rated in 42 other conditions, according to our data. His clinical expertise encompasses Huntington Disease, Movement Disorders, Drug Induced Dyskinesia, and Parkinson's Disease. Dr. Dayalu is board certified in Neurology.

Punithavathy Vijayakumar is a Neurologist and a Sleep Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Vijayakumar is rated as an Experienced provider by MediFind in the treatment of Lewy Body Dementia (LBD). She is also highly rated in 29 other conditions, according to our data. Her clinical expertise encompasses Multiple Sclerosis (MS), Obstructive Sleep Apnea, Transient Ischemic Attack (TIA), and Migraine. Dr. Vijayakumar is board certified in Clinical Neurophysiology, Neurology, Neuromuscular Medicine, Sleep Medicine, and Vascular Neurology.

Susan Maixner is a Palliative Medicine specialist and a Psychiatrist practicing medicine in Ann Arbor, Michigan. Dr. Maixner is rated as a Distinguished provider by MediFind in the treatment of Lewy Body Dementia (LBD). She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Bipolar Disorder (BPD), Major Depression, Seasonal Affective Disorder (SAD), and Lewy Body Dementia (LBD). Dr. Maixner is board certified in Hospice & Palliative Med, Psychiatry, and Geriatric Psychiatry.

Rachel Denny is a primary care provider, practicing in Internal Medicine and Geriatrics in Ann Arbor, Michigan. Dr. Denny is rated as an Experienced provider by MediFind in the treatment of Lewy Body Dementia (LBD). Her clinical expertise encompasses Delirium, Lewy Body Dementia (LBD), Neuronal Intranuclear Inclusion Disease (NIID), and Heart Failure. Dr. Denny is board certified in Family Medicine and Geriatric Medicine.

Kirk Frey is a Neurologist and a Nuclear Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Frey is rated as an Advanced provider by MediFind in the treatment of Lewy Body Dementia (LBD). He is also highly rated in 32 other conditions, according to our data. His clinical expertise encompasses Parkinson's Disease, Movement Disorders, Neuroendocrine Tumor, Osteopenia, and Hormone Replacement Therapy (HRT).

Nicolaas Bohnen is a Neurologist and a Nuclear Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Bohnen is rated as an Advanced provider by MediFind in the treatment of Lewy Body Dementia (LBD). He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Parkinson's Disease, Movement Disorders, Osteopenia, Melorheostosis, and Deep Brain Stimulation.

Dr. Manu received her medical degree at the University of Medicine and Pharmacy, Timisoara, Romania. She completed a physical medicine and rehabilitation residency at Baile Felix Rehabilitation Hospital, Oradea, Romania, and an internal medicine residency at St. Joseph Mercy Hospital, Pontiac. Dr. Manu completed a fellowship in geriatric medicine at the University of Michigan. She is board certified in hospice and palliative medicine. She has a special clinical interest in palliative medicine applied to the care of older adults, with focus on dementia care and education for healthcare providers and caregivers. Her research interests include geriatric and palliative medical education. Dr. Fulop is rated as an Advanced provider by MediFind in the treatment of Lewy Body Dementia (LBD). She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Lewy Body Dementia (LBD), Cerebellar Degeneration, Hypertension, and Familial Hypertension. Dr. Fulop is board certified in Geriatric Medicine and Hospice & Palliative Med.

Roger L. Albin, M.D. (Residency 1986), is a professor of neurology, associate chair for research and co-director of the Movement Disorders Clinic in the Department of Neurology in the University of Michigan Medical School. In addition, he serves as chief of neuroscience research at the VA Ann Arbor Healthcare System Geriatric Research Education and Clinical Center.Dr. Albin joined the U-M faculty in 1988 as an instructor in the Department of Neurology. He was promoted to assistant professor in 1989; associate professor in 1994; and achieved his current rank of full professor in 2000.After completing his undergraduate degree at Oberlin College in Ohio, Dr. Albin earned his medical degree from the University of Pittsburgh School of Medicine in 1982, and completed his residency at the University of Michigan in 1986. He also completed a movement disorders fellowship in 1988 under Drs. Anne Young and John Penney.His clinical and research interests include the underlying neurobiologic causes of the clinical features of movement disorders, basal ganglia structure and function, Parkinson's disease, Tourette syndrome, dementias, dystonias and Huntington's disease. His laboratory is pursuing work on basic mechanisms of neurodegeneration in Huntington disease using mouse genetic models. Dr. Albin also has participated in neuroprotective clinical trials for both Huntington's disease and Parkinson's disease.The present focus of Dr. Albin's group is uncovering the basis for non-motor (sleep disorders, depression, dementia, autonomic dysfunction) problems in Parkinson's disease. He is very interested in applying positron emission tomography (PET) imaging methods to improve diagnosis of dementing disorders like Alzheimer's disease. The hope is that understanding how specific brain alterations cause specific clinical features will lead to improved treatments.Dr. Albin currently serves as a site investigator for the National Institutes of Health (NIH) Exploratory Trials in Parkinson disease (NET-PD) initiative. His work is supported by grants from the NIH, the Michael J. Fox Foundation and the High Q Foundation.A member of the American Academy of Neurology, the American Association for the Advancement of Science, the American Neurologic Association, and the Society for Neuroscience, Dr. Albin currently serves on the editorial boards of Experimental Neurology, Neurology and Neurobiology of Disease. Dr. Albin is rated as an Advanced provider by MediFind in the treatment of Lewy Body Dementia (LBD). He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Movement Disorders, Parkinson's Disease, Huntington Disease, Dementia, and Deep Brain Stimulation. Dr. Albin is board certified in Neurology.

Navid Seraji-Bozorgzad, MD, is an associate professor of neurology in the University of Michigan Medical School.Dr. Seraji-Bozorgzad began work in the area of medical imaging in 1990 as a research assistant during his undergraduate studies at the University of Michigan. He became familiar and developed a fundamental understanding of image acquisition and processing from his work on solid-state imaging arrays. After undergraduate work, he worked in the private sector as a software engineer, designing databases for various companies, including Ford Motor Company, and Liberty Mutual Insurance. The work provided him with experience in data-mining and manipulation of large datasets.His passion for medicine eventually led him to medical school. During the application process he worked in the Department of Psychiatry and Behavioral Neurosciences, and eventually enrolled in graduate school in neuroscience. While in the Department of Psychiatry, he participated in the use of various MR imaging techniques, including magnetic resonance spectroscopy and functional MRI for diagnosis and disease progression in mood disorders, including bipolar disorder. It was during his graduate studies that he developed an interest in the field of neurodegeneration, regeneration and neuroprotection.Dr. Seraji-Bozorgzad's research interest is primarily with non-invasive methods of monitoring disease progression in neurodegenerative disorders, with the ultimate goal of developing a tool set to monitor the efficacy of therapies early on in neurodegenerative disorders.His bibliography includes numerous peer-reviewed jornals and publications, abstracts and other media. Dr. Seraji is rated as an Advanced provider by MediFind in the treatment of Lewy Body Dementia (LBD). He is also highly rated in 39 other conditions, according to our data. His clinical expertise encompasses Cerebellar Degeneration, Dementia, Vascular Dementia, and Alzheimer's Disease.

Kelvin L. Chou, M.D. is a Clinical Professor in the Departments of Neurology and Neurosurgery at Michigan Medicine and was the inaugural Thomas H. and Susan C. Brown Early Career Professor in Neurology. Dr. Chou has been named to the Best Doctors of America list since 2011 and sees all patients with movement disorders (i.e. Parkinson’s disease, tremors, dystonia, Huntington disease), though he has a particular interest in Parkinson’s disease (PD) and deep brain stimulation (DBS). Dr. Chou serves as Co-Director of the STIM (Surgical Therapies Improving Movement) Program and his research focus is on improving the ability to treat movement disorders patients through DBS. He is also an experienced clinical trialist, conducting numerous clinical trials on new therapies for PD, essential tremor and Huntington disease. He directs the Neurology Clinical Trials Organization (NeCTO) and is Lead Medical Director of the Neuroscience and Sensory Clinical Trials Support Unit (CTSU) at Michigan Medicine. He has published over 100 peer-reviewed journal articles, review articles or book chapters on PD and related movement disorders. A strong patient advocate, Dr. Chou is the Education and Outreach Core Director for the U-M Udall Center of Excellence for PD Research and serves on the Professional Advisory Board of the Michigan Parkinson Foundation and the Medical Advisory Board of the International Essential Tremor Foundation (IETF). He has also authored a book for patients and families called Deep Brain Stimulation: A New Life for People with Parkinson's, Dystonia and Essential Tremor. Dr. Chou is rated as an Advanced provider by MediFind in the treatment of Lewy Body Dementia (LBD). He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Parkinson's Disease, Movement Disorders, Essential Tremor, Drug Induced Dyskinesia, and Deep Brain Stimulation. Dr. Chou is board certified in Neurology.

Kara J. Wyant, MD, is a clinical lecturer in the Department of Neurology. She received her bachelor’s degrees in mathematics and music from Ohio Northern University, and medical degree from the University of Toledo College of Medicine. Dr. Wyant completed her neurology residency training at the University of Pittsburgh Medical Center, where she served as chief resident from 2015-2016. She is currently pursuing a fellowship in movement disorders at the University of Michigan focusing on the medical and surgical management of patients with Parkinson disease and parkinsonism. Dr. Wyant also serves on the neurohospitalist service at University Hospital, and participates in teleneurology consults for MidMichigan Health. Dr. (md) is rated as an Advanced provider by MediFind in the treatment of Lewy Body Dementia (LBD). She is also highly rated in 31 other conditions, according to our data. Her clinical expertise encompasses Drug Induced Dyskinesia, Parkinson's Disease, Movement Disorders, Dopa-Responsive Dystonia, and Deep Brain Stimulation. Dr. (md) is board certified in Neurology.

Dr. Suh received his M.D. and Ph.D. from the University of Cincinnati College of Medicine, and his Master of Health Science degree from Duke University. He completed his internal medicine residency at Cleveland Clinic and fellowship training in geriatric medicine at Duke University and Durham VA Medical Center. Dr. Suh has been board-certified in internal medicine and geriatric medicine. His clinical and research interests include geriatric and functional assessment, geriatric consultation, dementia care, fall prevention, osteoporosis, oral health, sleep disorders, medication use in older adults, and telehealth.Dr. Suh is a faculty member at both the University of Michigan and the Ann Arbor VA Hospital, and he serves as Medical Director of Turner Geriatric Clinic at East Ann Arbor for Michigan Medicine. Dr. Suh is a Fellow of the American Geriatrics Society (AGS) and serves as the Co-Chair for the Oral Health and Aging Special Interest Group for AGS. Ypsilanti, MI. Dr. Suh is rated as an Advanced provider by MediFind in the treatment of Lewy Body Dementia (LBD). He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Glucocorticoid-Remediable Aldosteronism, Hypertension, Familial Hypertension, and Sciatica. Dr. Suh is board certified in Geriatric Medicine.

Dr. Almeda received her medical degree from Michigan State University College of Osteopathic Medicine in East Lansing, Michigan in 1998. She completed her Internal Medicine residency at McLaren Macomb Hospital in Mount Clemens, Michigan and then her Geriatrics fellowship at the University of Michigan in Ann Arbor in 2002. She is board certified in Geriatrics and is a Fellow in the American College of Osteopathic Internists. After spending 12 years as a house call physician serving frail, homebound, older adults, she rejoined her alma mater in 2014 as a Clinical Instructor in the Division of Geriatrics at the University of Michigan, where she helps educate medical students, Internal Medicine residents, and Geriatric and Palliative Care Fellows in the outpatient setting. In April 2020 she was named Medical Director at Huron Valley PACE, a comprehensive program in Ypsilanti that helps nursing home eligible older adults remain in their homes until the end of their life. Dr. Almeda is rated as an Advanced provider by MediFind in the treatment of Lewy Body Dementia (LBD). She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Colitis, Lewy Body Dementia (LBD), Hypertension, and Glucocorticoid-Remediable Aldosteronism. Dr. Almeda is board certified in Geriatric Medicine.

Benjamin Bly is a Neurologist practicing medicine in Ann Arbor, Michigan. Dr. Bly is rated as an Advanced provider by MediFind in the treatment of Lewy Body Dementia (LBD). He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Lewy Body Dementia (LBD), Cerebellar Degeneration, Alzheimer's Disease, and Memory Loss.

Dr. Fine is an honors graduate of Harvard University and the U-M Medical School. He completed his internal medicine residency and served as chief medical resident at the U-M Medical Center. Dr. Fine was cited recently in The Best Doctors in America: Midwest Edition, 2017-2018. He enjoys piano and poetry composition, reading and music.Read Dr. Fine's 8 questions profile. Dr. Fine is rated as an Experienced provider by MediFind in the treatment of Lewy Body Dementia (LBD). He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Sickle Cell Disease, Familial Hypertension, Glucocorticoid-Remediable Aldosteronism, Colonoscopy, and Balloon Sinuplasty.

Ann Little is a Neurologist and a Neuroradiologist practicing medicine in Ann Arbor, Michigan. Dr. Little is rated as an Experienced provider by MediFind in the treatment of Lewy Body Dementia (LBD). She is also highly rated in 63 other conditions, according to our data. Her clinical expertise encompasses Inclusion Body Myositis, Polymyositis, Myasthenia Gravis, Stent Placement, and Transmyocardial Revascularization.

Dr. Allison Ruff graduated from the University of Florida before obtaining her medical degree at the University of Miami Miller School of Medicine. She completed her internal medicine training at the Cleveland Clinic in Cleveland, OH, where she also served as Chief Medical Resident. her clinical interests include primary care of medically complex adults, women's health, preventative medicine, and medical education. She lives in Ann Arbor with her husband and three children. Dr. Ruff is rated as an Experienced provider by MediFind in the treatment of Lewy Body Dementia (LBD). Her clinical expertise encompasses Type 2 Diabetes (T2D), Migraine, Maturity Onset Diabetes of the Young, and Osteopetrosis Autosomal Recessive Type 3.